Patients with symptoms of PAP but a low level or absence of GM-CSF AAbs (effectively excluding the diagnosis of aPAP) should be assessed for GM-CSF functional signaling and serum GM-CSF concentration (Figure 3) (79). This evidence concerns the gene CSF2 and pulmonary alveolar proteinosis.